Industry Veteran Joins Noxilizer’s Leadership Team to Build European Operations

Noxilizer, Inc. — the company advancing a room temperature, NO₂-based sterilisation process for life science manufacturers — has appointed Stephen Morley as Vice President, European Sales and Service, Noxilizer Ltd, the newly established entity for Noxilizer’s European sales and service operations. Noxilizer’s entrance into Europe, the next step in their global expansion strategy, is intended to accelerate the global acceptance of nitrogen dioxide sterilisation as a powerful, efficient and cost-saving alternative to traditional sterilisation methods.

This announcement follows Noxilizer’s Spring 2013 asset acquisition of SAIAN Corporation and the creation of Noxilizer Japan KK, establishing Noxilizer as a global player in the life science sterilisation market.

“Well-regarded in the industry, Steve has a demonstrated track record of building strategic partnerships and developing business opportunities that have resulted in strong revenue growth,” noted Lawrence Bruder, Noxilizer CEO. “We are confident his leadership will be an asset as we establish our European presence and grow the sterilisation business.”

Morley joins Noxilizer with 30 years of successful operational and strategic business development experience. He led a distinguished career with Getinge Group, where he held positions of progressive leadership, most recently serving as Portfolio Manager with Getinge Infection Control AB. Among his notable achievements, Morley established operations for Getinge in Japan, led the integration of acquired companies and helped establish centralised marketing and business development activities for the organisation. Morley holds an honours degree in Physics and Chemistry from Nottingham University.

"This is an exciting opportunity. I am pleased to join an organisation whose leadership is committed to delivering a new sterilisation solution to customers,” said Morley. “I also look forward to introducing the European market to the exceptional technological advantages of NO₂ sterilisation.”

NO₂ sterilisation eliminates preconditioning, maintains material properties in heat-sensitive products and does not require long aeration. It is gaining recognition as an ideal sterilisation alternative for pressure and temperature sensitive products. In addition to the technological advantages of NO₂, customers are recognising the potential manufacturing efficiencies and resulting cost savings.

Morley will conduct business from the UK-based, Noxilizer Ltd office. Noxilizer’s headquarters will remain in Baltimore, Maryland, US.

Noxilizer Ltd, +44 1246 570777, smorley@noxilizer.com, www.noxilizer.com.